Mental and behavioural disorders due to use of other stimulants, including caffeine

F5_STIMUL

No definition available.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 F15
Hospital discharge: ICD-9 3044|3057
Hospital discharge: ICD-8 3046
Cause of death: ICD-10 F15
Cause of death: ICD-9 3044|3057
Cause of death: ICD-8 3046

2 out of 7 registries used, show all original rules.

913

diagram downward connector

Check minimum number of events None

913

diagram downward connector

Include endpoints None

913

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

856

diagram downward connector
F5_STIMUL

Control definitions

Control exclude F5_SUBSNOALCO

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 F10-F19
Name in latin Perturbationes mentis et modi se gerendi ex usu aliorum stimulantium (coffeino incluso)

Summary Statistics

Key figures

All Female Male
Number of individuals 856 340 516
Unadjusted prevalence (%) 0.23 0.16 0.31
Mean age at first event (years) 28.79 27.85 29.40

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.36 29.68 [15.66, 56.25] 2.7e-25 40
15 years 0.14 24.10 [12.13, 47.88] 1.0e-19 18
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: F5_STIMUL – Mental and behavioural disorders due to use of other stimulants, including caffeine
GWS hits:

Survival analyses between endpoints

Plot

before Mental and behavioural disorders due to use of other stimulants, including caffeine
after Mental and behavioural disorders due to use of other stimulants, including caffeine

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Mental and behavioural disorders due to use of other stimulants, including caffeine

Endpoint not on priority list, no data to show.